Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
Public ClinicalTrials.gov record NCT01053936. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Open-Label, Randomized, Parallel Group, Dose-Ranging, Pharmacodynamic Phase II Trial to Determine the Effects of Bardoxolone Methyl (RTA 402, Amorphous Dispersion) on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease (eGFR 15-45 mL/Min/1.73m2)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study assesses the effects of a new formulation of bardoxolone methyl on eGFR in Patients with Chronic Kidney Disease and Type 2 Diabetes.
Study identification
- NCT ID
- NCT01053936
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 129 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2010 (Actual)
- Primary completion
- Dec 31, 2010 (Actual)
- Completion
- Feb 28, 2011 (Actual)
- Last update posted
- May 29, 2025
2010 – 2011
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Montgomery | Alabama | 36106 | — |
| Not listed | Phoenix | Arizona | 85012 | — |
| Not listed | Tempe | Arizona | 85284 | — |
| Not listed | La Mesa | California | 91942 | — |
| Not listed | Riverside | California | 92505 | — |
| Not listed | San Dimas | California | 91773 | — |
| Not listed | Washington D.C. | District of Columbia | 20036 | — |
| Not listed | Brandon | Florida | 33511 | — |
| Not listed | Port Charlotte | Florida | 33952 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Augusta | Georgia | 30901 | — |
| Not listed | Canton | Georgia | 30114 | — |
| Not listed | Chicago | Illinois | 60616 | — |
| Not listed | Peoria | Illinois | 61603 | — |
| Not listed | Brooklyn Center | Minnesota | 55430 | — |
| Not listed | Morehead City | North Carolina | 28557 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Pittsburgh | Pennsylvania | 15224 | — |
| Not listed | Providence | Rhode Island | 02904 | — |
| Not listed | Chattanooga | Tennessee | 37304 | — |
| Not listed | Corpus Christi | Texas | 78404 | — |
| Not listed | Dallas | Texas | 75390 | — |
| Not listed | Greenville | Texas | 75402 | — |
| Not listed | Houston | Texas | 77099 | — |
| Not listed | San Antonio | Texas | 78215 | — |
| Not listed | Federal Way | Washington | 98003 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01053936, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 29, 2025 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01053936 live on ClinicalTrials.gov.